Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Other Working Capital Changes (2020 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Other Working Capital Changes for 4 consecutive years, with $2.4 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Other Working Capital Changes rose 1659.35% year-over-year to $2.4 million, compared with a TTM value of $1.9 million through Dec 2023, up 414.92%, and an annual FY2024 reading of -$555000.0, down 128.89% over the prior year.
  • Other Working Capital Changes was $2.4 million for Q4 2023 at Terns Pharmaceuticals, up from -$1.1 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $2.4 million in Q4 2023 and bottomed at -$2.3 million in Q3 2022.
  • Average Other Working Capital Changes over 4 years is $69357.1, with a median of -$103500.0 recorded in 2022.
  • The sharpest move saw Other Working Capital Changes tumbled 32900.0% in 2022, then soared 1659.35% in 2023.
  • Year by year, Other Working Capital Changes stood at $864000.0 in 2020, then tumbled by 128.36% to -$245000.0 in 2021, then skyrocketed by 36.73% to -$155000.0 in 2022, then skyrocketed by 1659.35% to $2.4 million in 2023.
  • Business Quant data shows Other Working Capital Changes for TERN at $2.4 million in Q4 2023, -$1.1 million in Q3 2023, and $804000.0 in Q2 2023.